首页> 外文OA文献 >Exploring the Roles of the Histone Deacetylase and Longevity Factor SIRT6 in Cancer.
【2h】

Exploring the Roles of the Histone Deacetylase and Longevity Factor SIRT6 in Cancer.

机译:探讨组蛋白去乙酰化酶和长寿因子sIRT6在癌症中的作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Identification of pathways that regulate longevity in an evolutionarily conserved manner is a major focus of modern biogerontology. Interest in the sirtuin family of deacetylases/ADP-ribosyltransferases/deacylases began with the observation that increased expression of SIR2 extends replicative lifespan in budding yeast. The seven mammalian sirtuin homologs have been the focus of intense investigation for their potential impacts on health- and lifespan. My thesis work focuses specifically on the mammalian sirtuin SIRT6. SIRT6 plays multiple roles in metabolic homeostasis and genome integrity through modification of histones and other protein targets; consequently SIRT6 suppresses many age-associated pathologies such as neoplasia, cardiac hypertrophy, and glucose intolerance. SIRT6 overexpression results in extended lifespan in male mice, suggesting that SIRT6 may represent a true functional ortholog of yeast SIR2, and supporting an evolutionarily conserved role for sirtuins in longevity. In this work, we identified a protective role for SIRT6 in suppressing tumorigenesis. First, SIRT6 suppresses aerobic glycolysis, the preferred form of energy metabolism in cancer cells, by inhibiting the expression of various glycolytic proteins. Second, SIRT6 regulates cell growth by reducing ribosomal biogenesis via the proto-oncogene c-MYC. Additionally, we identified H3K56ac, a histone mark involved in DNA repair which is often elevated in cancer, as a novel target for SIRT6 and we identified an increased incidence of aneuploidy in SIRT6-deficient cells. Thus, SIRT6’s role in maintaining genomic integrity could possibly provide a third means through which SIRT6 suppresses tumor development. Conversely, examination of established cancer cell lines and tissues, revealed high SIRT6 protein expression and cytoplasmic localization. However, SIRT6 activity appears to be compromised as SIRT6 no longer acts upon its target H3K56. Overall, the identified tumor suppressive properties of SIRT6 are possibly the underlying mechanism through which SIRT6 extends mammalian lifespan, and provides therapeutic potential for the treatment of various malignancies.
机译:鉴定以进化保守方式调节寿命的途径是现代生物老年医学的主要重点。对Sirtuin脱乙酰基酶/ ADP-核糖基转移酶/脱酰基酶家族的兴趣始于观察到SIR2表达增加会延长发芽酵母中的复制寿命。七个哺乳动物的瑟土因同系物因其对健康和寿命的潜在影响而成为广泛研究的焦点。我的论文工作专门针对哺乳动物的瑟土因SIRT6。 SIRT6通过修饰组蛋白和其他蛋白质靶标,在代谢稳态和基因组完整性中发挥多种作用。因此,SIRT6抑制了许多与年龄相关的病理,例如肿瘤,心脏肥大和葡萄糖耐量异常。 SIRT6的过表达导致雄性小鼠的寿命延长,这表明SIRT6可能代表酵母SIR2的真正功能直系同源物,并支持长寿蛋白在进化上的保守作用。在这项工作中,我们确定了SIRT6在抑制肿瘤发生中的保护作用。首先,SIRT6通过抑制各种糖酵解蛋白的表达来抑制有氧糖酵解,这是癌细胞中能量代谢的首选形式。其次,SIRT6通过减少原核基因c-MYC的核糖体生物发生来调节细胞生长。此外,我们将H3K56ac(一种参与DNA修复的组蛋白标记,通常在癌症中升高)识别为SIRT6的新靶标,并且发现SIRT6缺陷细胞中非整倍性的发生率增加。因此,SIRT6在维持基因组完整性方面的作用可能提供了SIRT6抑制肿瘤发展的第三种方法。相反,对已建立的癌细胞系和组织的检查显示,SIRT6蛋白表达高且细胞质定位。但是,SIRT6的活性似乎受到了损害,因为SIRT6不再对其目标H3K56起作用。总体而言,SIRT6的肿瘤抑制特性可能是SIRT6延长哺乳动物寿命的潜在机制,并为各种恶性肿瘤的治疗提供了治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号